Your browser doesn't support javascript.
loading
The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: A Re-Assessment of the International Thymic Malignancy Interest Group/International Association for the Study of Lung Cancer Lymph Node Map for Thymic Epithelial Tumors for the Forthcoming Ninth Edition of the TNM Classification of Malignant Tumors.
Marom, Edith M; Fang, Wentao; Ruffini, Enrico; Detterbeck, Frank; Ahmad, Usman; Appel, Sarit; Bille, Andrea; Boubia, Souheil; Brambilla, Cecilia; Cilento, Vanessa; Cangir, Ayten Kayi; Falkson, Conrad; Filosso, Pier Luigi; Giaccone, Giuseppe; Girard, Nicolas; Goren, Emily; Guerrera, Francesco; Huang, James; Infante, Maurizio; Kim, Dong-Kwan; Lucchi, Marco; Marino, Mirella; Nicholson, Andrew G; Okumura, Meinoshin; Rami-Porta, Ramon; Rimner, Andreas; Simone, Charles B; Asamura, Hisao.
Afiliação
  • Marom EM; Department of Diagnostic Imaging, Chaim Sheba Medical Center, Tel-Aviv University, Ramat Gan, Israel.
  • Fang W; Shanghai Chest Hospital, Jiaotong University Medical School, Shanghai, People's Republic of China.
  • Ruffini E; University of Torino, Torino, Italy. Electronic address: enrico.ruffini@unito.it.
  • Detterbeck F; Yale University School of Medicine, New Haven, Connecticut.
  • Ahmad U; Thoracic Surgery in the Heart, Vascular & Thoracic Institute at Cleveland Clinic, Abu Dhabi, United Arab Emirates.
  • Appel S; Sheba Medical Center, Ramat Gan, Israel.
  • Bille A; Guy's Hospital, London, United Kingdom.
  • Boubia S; University Hospital Ibn Rochd, Casablanca, Morocco.
  • Brambilla C; Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Cilento V; Cancer Research And Biostatistics (CRAB), Seattle, Washington.
  • Cangir AK; Ankara University Faculty of Medicine, Ankara, Turkey.
  • Falkson C; Queen's University in Kingston, Ontario, Canada.
  • Filosso PL; Baggiovara Civil Hospital, University of Modena, Modena, Italy.
  • Giaccone G; Meyer Cancer Center, Weill-Cornell Medicine, New York, New York.
  • Girard N; Institut Curie, Thorax Institute Curie Montsouris, Paris, France; Paris Saclay University, UVSQ, Versailles, France.
  • Goren E; Cancer Research And Biostatistics (CRAB), Seattle, Washington.
  • Guerrera F; University of Torino, Torino, Italy.
  • Huang J; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Infante M; University and Hospital Trust, Verona, Italy.
  • Kim DK; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Lucchi M; Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Marino M; IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Nicholson AG; Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Okumura M; National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan.
  • Rami-Porta R; Hospital Universitari Mutua Terrassa, Terrassa, Spain, and Network of Centers for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Spain.
  • Rimner A; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Simone CB; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Asamura H; Keio University, Tokyo, Japan.
J Thorac Oncol ; 18(12): 1672-1688, 2023 12.
Article em En | MEDLINE | ID: mdl-37689390
ABSTRACT

INTRODUCTION:

A lymph node map is the pillar on which accurate assignment and documentation of nodal classification stands. The International Thymic Malignancy Interest Group created the first map for thymic epithelial malignancies in conjunction with the eighth edition of the TNM classification, representing the first official TNM classification of thymic epithelial malignancies. The map was based on clinical experience and published studies, but it was largely empirical because of limited available data. Dissemination of the map and implementation of a standard thymic stage classification across the world in 2017 have provided more consistent and granular data.

METHODS:

More than twice as many cases of node involvement are available for analysis in the current database compared with that of the eighth edition database, allowing validation of many aspects of the eighth edition map. This article details the process and considerations for refinement of the thymic map for the ninth TNM used by the Thymic Domain of the Staging and Prognostic Factors Committee of the International Association for the Study of Lung Cancer. The committee evaluated a large international collaborative data set, published anatomical and clinical studies pertaining to lymph node spread from thymic epithelial tumors, in conjunction with the analysis underlying refinements of the TNM components for the ninth edition TNM classification.

RESULTS:

The node map boundaries of the N1 and N2 categories remain unchanged. Visual clarifications have been added to the nomenclature of nodal stations within these regions.

CONCLUSIONS:

On the basis of the recommendation to keep the N component unchanged for the ninth edition TNM classification, the lymph node map remains unchanged as well; however, clarifications have been added to facilitate clinical use.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Timo / Neoplasias Epiteliais e Glandulares / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Timo / Neoplasias Epiteliais e Glandulares / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article